Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Mathias Oymanns"'
Publikováno v:
Current Oncology, Vol 31, Iss 9, Pp 5412-5421 (2024)
Patients with advanced-stage mycosis fungoides (MF IIB–IVB) and Sézary syndrome (SS) have poor prognoses, with survival ranging from 4.7 to 1.4 years depending on the disease stage. There is a need for therapeutic approaches that lead to long-last
Externí odkaz:
https://doaj.org/article/3898995f466c441c99031f9d4b5c5169
Publikováno v:
Case Reports in Dermatology, Vol 13, Iss 3, Pp 563-567 (2021)
Multiple myeloma is a lymphoproliferative disease, which rarely presents with skin involvement or associated symptoms. Better awareness of these dermatological presentations is required for early diagnosis and to guide the patient towards appropriate
Externí odkaz:
https://doaj.org/article/0a4b2be4f4654bef86cf66a33c3fafb3
Autor:
Mathias Oymanns, Michael Daum-Marzian, Aliyah Bellm, Khaled Elsayad, Hans T Eich, Chalid Assaf
Publikováno v:
British Journal of Dermatology. 188:145-146
Patients with advanced stage mycosis fungoides (MF) or Sézary syndrome (SS) have a poor prognosis. Despite many available active single agents for CTCL treatment, high remission rates and long-lasting responses are rarely achieved in advanced CTCL [
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f0190389d6e493eee64c0f62b5e5dbbe
https://doi.org/10.1093/bjd/ljac012
https://doi.org/10.1093/bjd/ljac012